Annual Accounts Payable
$8.88 M
+$5.73 M+182.06%
December 1, 2024
Summary
- As of March 10, 2025, SLNO annual accounts payable is $8.88 million, with the most recent change of +$5.73 million (+182.06%) on December 1, 2024.
- During the last 3 years, SLNO annual accounts payable has risen by +$5.63 million (+172.96%).
- SLNO annual accounts payable is now at all-time high.
Performance
SLNO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.88 M
+$2.64 M+42.27%
December 1, 2024
Summary
- As of March 10, 2025, SLNO quarterly accounts payable is $8.88 million, with the most recent change of +$2.64 million (+42.27%) on December 1, 2024.
- Over the past year, SLNO quarterly accounts payable has stayed the same.
- SLNO quarterly accounts payable is now at all-time high.
Performance
SLNO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SLNO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +182.1% | 0.0% |
| 3 y3 years | +173.0% | 0.0% |
| 5 y5 years | +345.2% | 0.0% |
SLNO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +399.8% | at high | +399.8% |
| 5 y | 5-year | at high | +399.8% | at high | +399.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Soleno Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $8.88 M(+182.1%) | $8.88 M(+42.3%) |
| Sep 2024 | - | $6.24 M(+68.0%) |
| Jun 2024 | - | $3.72 M(-53.7%) |
| Mar 2024 | - | $8.02 M(+154.7%) |
| Dec 2023 | $3.15 M(+77.2%) | $3.15 M(-2.1%) |
| Sep 2023 | - | $3.22 M(-6.6%) |
| Jun 2023 | - | $3.44 M(+23.9%) |
| Mar 2023 | - | $2.78 M(+56.3%) |
| Dec 2022 | $1.78 M(-45.4%) | $1.78 M(-23.5%) |
| Sep 2022 | - | $2.32 M(-3.4%) |
| Jun 2022 | - | $2.41 M(-0.2%) |
| Mar 2022 | - | $2.41 M(-25.9%) |
| Dec 2021 | $3.25 M(-6.7%) | $3.25 M(-15.7%) |
| Sep 2021 | - | $3.86 M(+15.2%) |
| Jun 2021 | - | $3.35 M(-28.3%) |
| Mar 2021 | - | $4.67 M(+33.8%) |
| Dec 2020 | $3.49 M(+74.9%) | $3.49 M(+8.6%) |
| Sep 2020 | - | $3.21 M(-12.1%) |
| Jun 2020 | - | $3.66 M(+5.1%) |
| Mar 2020 | - | $3.48 M(+74.4%) |
| Dec 2019 | $2.00 M | $2.00 M(+15.0%) |
| Sep 2019 | - | $1.74 M(-0.3%) |
| Jun 2019 | - | $1.74 M(+38.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.26 M(+34.7%) |
| Dec 2018 | $934.00 K(+47.6%) | $934.00 K(-25.0%) |
| Sep 2018 | - | $1.25 M(+26.9%) |
| Jun 2018 | - | $981.00 K(-13.4%) |
| Mar 2018 | - | $1.13 M(+79.0%) |
| Dec 2017 | $633.00 K(+54.2%) | $633.00 K(-1.4%) |
| Sep 2017 | - | $642.00 K(-37.6%) |
| Jun 2017 | - | $1.03 M(+10.1%) |
| Mar 2017 | - | $935.00 K(+127.8%) |
| Dec 2016 | $410.50 K(-40.9%) | $410.50 K(-52.4%) |
| Sep 2016 | - | $862.00 K(-9.9%) |
| Jun 2016 | - | $957.00 K(-24.2%) |
| Mar 2016 | - | $1.26 M(+81.6%) |
| Dec 2015 | $695.10 K(-29.6%) | $695.10 K(-27.1%) |
| Sep 2015 | - | $953.00 K(-3.6%) |
| Jun 2015 | - | $989.00 K(+59.3%) |
| Mar 2015 | - | $621.00 K(-37.1%) |
| Dec 2014 | $986.80 K(+1610.2%) | $986.80 K(-20.3%) |
| Sep 2014 | - | $1.24 M(+93.6%) |
| Jun 2014 | - | $639.30 K(+619.9%) |
| Mar 2014 | - | $88.80 K(+53.9%) |
| Dec 2013 | $57.70 K(-73.7%) | $57.70 K |
| Dec 2012 | $219.50 K | - |
FAQ
- What is Soleno Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Soleno Therapeutics?
- What is Soleno Therapeutics annual accounts payable year-on-year change?
- What is Soleno Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly accounts payable year-on-year change?
What is Soleno Therapeutics annual accounts payable?
The current annual accounts payable of SLNO is $8.88 M
What is the all time high annual accounts payable for Soleno Therapeutics?
Soleno Therapeutics all-time high annual accounts payable is $8.88 M
What is Soleno Therapeutics annual accounts payable year-on-year change?
Over the past year, SLNO annual accounts payable has changed by +$5.73 M (+182.06%)
What is Soleno Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SLNO is $8.88 M
What is the all time high quarterly accounts payable for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly accounts payable is $8.88 M
What is Soleno Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SLNO quarterly accounts payable has changed by $0.00 (0.00%)